Peer-Led Team Learning Helps Minority Students Succeed von Snyder, Julia J, Sloane, Jeremy D, Dunk, Ryan D P, Wiles, Jason R

Volltext

STIM1 Controls Neuronal Ca2+ Signaling, mGluR1-Dependent Synaptic Transmission, and Cerebellar Motor Behavior von Hartmann, Jana, Karl, Rosa M., Alexander, Ryan P.D., Adelsberger, Helmuth, Brill, Monika S., Rühlmann, Charlotta, Ansel, Anna, Sakimura, Kenji, Baba, Yoshihiro, Kurosaki, Tomohiro, Misgeld, Thomas, Konnerth, Arthur

Volltext

Bursting in cerebellar stellate cells induced by pharmacological agents: Non-sequential spike adding von Farjami, Saeed, Alexander, Ryan P D, Bowie, Derek, Khadra, Anmar

Volltext

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors von Balmaña, J., Tung, N.M., Isakoff, S.J., Graña, B., Ryan, P.D., Saura, C., Lowe, E.S., Frewer, P., Winer, E., Baselga, J., Garber, J.E.

Volltext

Intrinsic plasticity of cerebellar stellate cells is mediated by NMDA receptor regulation of voltage‐gated Na+ channels von Alexander, Ryan P.D., Bowie, Derek

Volltext

Peer-led team learning in an undergraduate biology course: Impacts on recruitment, retention, and imposter phenomenon von Maxwell, Mariah C, Snyder, Julia J, Dunk, Ryan D P, Sloane, Jeremy D, Cannon, Isabella, Wiles, Jason R

Volltext

Mechanisms of RNA-induced toxicity in CAG repeat disorders von Nalavade, R, Griesche, N, Ryan, D P, Hildebrand, S, Krauß, S

Volltext

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer von Hezel, A F, Noel, M S, Allen, J N, Abrams, T A, Yurgelun, M, Faris, J E, Goyal, L, Clark, J W, Blaszkowsky, L S, Murphy, J E, Zheng, H, Khorana, A A, Connolly, G C, Hyrien, O, Baran, A, Herr, M, Ng, K, Sheehan, S, Harris, D J, Regan, E, Borger, D R, Iafrate, A J, Fuchs, C, Ryan, D P, Zhu, A X

Volltext

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma von Chan, J.A., Blaszkowsky, L.S., Enzinger, P.C., Ryan, D.P., Abrams, T.A., Zhu, A.X., Temel, J.S., Schrag, D., Bhargava, P., Meyerhardt, J.A., Wolpin, B.M., Fidias, P., Zheng, H., Florio, S., Regan, E., Fuchs, C.S.

Volltext

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy von GARCIA-CARBONERO, R, SUPKO, J. G, MATULONIS, U, MAKI, R. G, LOPEZ, T, PUCHALSKI, T. A, SANCHO, M. A, GOMEZ, J, GUZMAN, C, JIMENO, J, DEMETRI, G. D, MANOLA, J, SEIDEN, M. V, HARMON, D, RYAN, D. P, QUIGLEY, M. T, MERRIAM, P, CANNIFF, J, GOSS, G

Volltext

Nanoscale Mobility of the Apo State and TARP Stoichiometry Dictate the Gating Behavior of Alternatively Spliced AMPA Receptors von Dawe, G. Brent, Kadir, Md. Fahim, Venskutonytė, Raminta, Perozzo, Amanda M., Yan, Yuhao, Alexander, Ryan P.D., Navarrete, Camilo, Santander, Eduardo A., Arsenault, Marika, Fuentes, Christian, Aurousseau, Mark R.P., Frydenvang, Karla, Barrera, Nelson P., Kastrup, Jette S., Edwardson, J. Michael, Bowie, Derek

Volltext

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study von GARCIA-CARBONERO, R, SUPKO, J. G, QUIGLEY, M. T, LOPEZ, T, SANCHO, M. A, JIMENO, J, GUZMAN, C, DEMETRI, G. D, MAKI, R. G, MANOLA, J, RYAN, D. P, HARMON, D, PUCHALSKI, T. A, GOSS, G, SEIDEN, M. V, WAXMAN, A

Volltext

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers von Schrader, K A, Masciari, S, Boyd, N, Salamanca, C, Senz, J, Saunders, D N, Yorida, E, Maines-Bandiera, S, Kaurah, P, Tung, N, Robson, M E, Ryan, P D, Olopade, O I, Domchek, S M, Ford, J, Isaacs, C, Brown, P, Balmana, J, Razzak, A R, Miron, P, Coffey, K, Terry, M B, John, E M, Andrulis, I L, Knight, J A, O'Malley, F P, Daly, M, Bender, P, Moore, R, Southey, M C, Hopper, J L, Garber, J E, Huntsman, D G

Volltext

A multifactorial analysis of acceptance of evolution von Dunk, Ryan D. P., Petto, Andrew J., Wiles, Jason R., Campbell, Benjamin C.

Volltext

Evaluating the current state of evolution acceptance instruments: a research coordination network meeting report von Barnes, M. Elizabeth, Aini, Rahmi Q., Collins, James P., Dunk, Ryan D. P., Holt, Emily A., Jensen, Jamie, Klein, Joanna R., Misheva, Taya, Nadelson, Louis S., Reiss, Michael J., Romine, William L., Shtulman, Andrew, Townley, Amanda L., Wiles, Jason R., Zheng, Yi, Brownell, Sara E.

Volltext

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer von Meyerhardt, JA, Stuart, K, Fuchs, CS, Zhu, AX, Earle, CC, Bhargava, P, Blaszkowsky, L, Enzinger, P, Mayer, RJ, Battu, S, Lawrence, C, Ryan, DP

Volltext

Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study von Michaelson, M D, Zhu, A X, Ryan, D P, McDermott, D F, Shapiro, G I, Tye, L, Chen, I, Stephenson, P, Patyna, S, Ruiz-Garcia, A, Schwarzberg, A B

Volltext

A comparison study of human examples vs. non-human examples in an evolution lesson leads to differential impacts on student learning experiences in an introductory biology course von Grunspan, Daniel Z., Dunk, Ryan D. P., Barnes, M. Elizabeth, Wiles, Jason R., Brownell, Sara E.

Volltext

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy von Chavarri-Guerra, Y, Higgins, M J, Szymonifka, J, Cigler, T, Liedke, P, Partridge, A, Ligibel, J, Come, S E, Finkelstein, D, Ryan, P D, Goss, P E

Volltext

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle von HAMILTON, A. L, EDER, J. P, KINCHLA, N, BOYDEN, J, YEE, H, ZELENIUCH-JACQUOTTE, A, WRIGHT, J, ELLIOTT, P, ADAMS, J, MUGGIA, F. M, PAVLICK, A. C, CLARK, J. W, LIEBES, L, GARCIA-CARBONERO, R, CHACHOUA, A, RYAN, D. P, SOMA, V, FARRELL, K

Volltext